{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T06:31:19Z","timestamp":1786343479170,"version":"build-2736575974"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Early recognition of heart failure with reduced ejection fraction (HFrEF) is clinically important because treatment pathways and prognosis differ across left ventricular ejection fraction phenotypes. When echocardiography is delayed, routinely available laboratory data may help prioritize patients for definitive imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This single-center retrospective study included 1,480 hospitalized patients with chronic heart failure, comprising 377 with HFrEF and 1,103 with HFmrEF\/HFpEF. Baseline laboratory indicators were obtained from the first blood draw within 24\u2005h of admission, and matched echocardiography was typically performed within 48\u2005h. After a stratified 7:3 train-test split, preprocessing, imputation, standardization, feature selection, and model training were conducted within a leakage-free machine-learning pipeline. Cross-validated recursive feature elimination retained 13 routine indicators: proBNP, HCT, TBil, DBil, BUN,\n                      <jats:italic>\u03b2<\/jats:italic>\n                      2-MG, CRP, UA, Glb, GGT, MCH, LDL-C, and FIB. Six algorithms were evaluated using discrimination, calibration, decision-curve analysis, threshold analysis, and SHAP interpretation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The HFrEF group showed higher proBNP, BUN, TBil, DBil, GGT, HCT, and UA levels than the HFmrEF\/HFpEF group. In the independent test set, random forest and XGBoost achieved the highest AUCs (both 0.789), whereas logistic regression showed comparable discrimination (AUC: 0.784) and strong calibration (intercept 0.017; slope 1.069). Random forest had the lowest Brier score (0.152), but pairwise bootstrap comparisons showed no statistically significant AUC differences among models. At the default threshold, sensitivity was limited; however, moving the random forest threshold to 0.15 increased sensitivity to 0.912 and negative predictive value to 0.935, supporting a rule-out triage strategy for prioritized echocardiography. SHAP analysis identified proBNP as the dominant predictor, followed by HCT, DBil, Glb, UA, GGT, TBil, and LDL-C.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A 13-indicator routine laboratory model provided moderate discrimination for distinguishing HFrEF from HFmrEF\/HFpEF. Random forest had the numerically most favorable balance of discrimination and calibration, but its clinical usefulness depends on threshold optimization rather than default classification. The model should be regarded as an adjunctive triage tool pending external and prospective validation, not as a substitute for echocardiographic phenotyping.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1856570","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T06:18:22Z","timestamp":1786342702000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning-based identification of heart failure with reduced ejection fraction using routine laboratory indicators"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhiping","family":"Meng","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, Guigang Clinical Medical Research Center for Medical Laboratory, Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People\u2019s Hospital","place":["Guigang, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhan","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Guigang Clinical Medical Research Center for Medical Laboratory, Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People\u2019s Hospital","place":["Guigang, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binbin","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Information Technology, The People Hospital of Guigang","place":["Guigang, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenpei","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The People Hospital of Guigang","place":["Guigang, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentan","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Guigang Clinical Medical Research Center for Medical Laboratory, Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People\u2019s Hospital","place":["Guigang, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guinian","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Guigang Clinical Medical Research Center for Medical Laboratory, Eighth Affiliated Hospital of Guangxi Medical University, Guigang City People\u2019s Hospital","place":["Guigang, Guangxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","article-title":"Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure","volume":"27","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e895","DOI":"10.1161\/CIR.0000000000001063","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.cjca.2023.04.022","article-title":"Canadian cardiovascular society-Canadian heart failure society focused clinical practice update of patients with differing heart failure phenotypes","volume":"39","author":"Ducharme","year":"2023","journal-title":"Can J Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejim.2022.05.030","article-title":"From mid-range to mildly reduced ejection fraction heart failure: a call to treat","volume":"103","author":"Stolfo","year":"2022","journal-title":"Eur J Intern Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ihj.2023.03.003","article-title":"SGLT2 inhibitors and cardiovascular outcomes in heart failure with mildly reduced and preserved ejection fraction: a systematic review and meta-analysis","volume":"75","author":"Banerjee","year":"2023","journal-title":"Indian Heart J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1161\/CIRCULATIONAHA.124.072156","article-title":"Evidence-based application of natriuretic peptides in the evaluation of chronic heart failure with preserved ejection fraction in the ambulatory outpatient setting","volume":"151","author":"Reddy","year":"2025","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jchf.2024.08.009","article-title":"Natriuretic peptides, kidney function,\u00a0and clinical outcomes in heart\u00a0failure\u00a0with preserved ejection\u00a0fraction","volume":"13","author":"Neuen","year":"2025","journal-title":"JACC Heart Fail"},{"key":"B8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.orcp.2024.05.005","article-title":"Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: the modifying role of obesity","volume":"18","author":"Palau","year":"2024","journal-title":"Obes Res Clin Pract"},{"key":"B9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12872-025-04700-0","article-title":"Evaluation of machine learning methods for prediction of heart failure mortality and readmission: meta-analysis","volume":"25","author":"Hajishah","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"B10","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1113\/JP281845","article-title":"Phenotyping heart failure using model-based analysis and physiology-informed machine learning","volume":"599","author":"Jones","year":"2021","journal-title":"J Physiol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"103462","DOI":"10.1016\/j.eclinm.2025.103462","article-title":"Machine learning-based phenotyping and assessment of treatment responses in heart failure with preserved ejection fraction","volume":"88","author":"Li","year":"2025","journal-title":"eClinicalMed"},{"key":"B12","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.jacasi.2024.09.003","article-title":"Predicting mortality and hospitalization in heart failure with preserved ejection fraction by using machine learning","volume":"4","author":"Chang","year":"2024","journal-title":"JACC Asia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD\u2009+\u2009AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"Br Med J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e082505","DOI":"10.1136\/bmj-2024-082505","article-title":"PROBAST\u2009+\u2009AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods","volume":"388","author":"Moons","year":"2025","journal-title":"Br Med J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10741-024-10442-6","article-title":"BNP and NT-proBNP as prognostic biomarkers for the prediction of adverse outcomes in HFpEF patients: a systematic review and meta-analysis","volume":"30","author":"Ammar","year":"2025","journal-title":"Heart Fail Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12872-025-04647-2","article-title":"Liver biomarkers as predictors of prognosis in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"25","author":"Dastjerdi","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"B17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/ejhf.3363","article-title":"Hypoalbuminaemia and heart failure: a practical review of current evidence","volume":"27","author":"Biancucci","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e20220523","DOI":"10.36660\/abc.20220523","article-title":"Prognostic significance of nutrition-associated markers in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"120","author":"Meng","year":"2023","journal-title":"Arq Bras Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.hrtlng.2023.03.001","article-title":"Prognostic value of liver damage assessed through direct bilirubin levels and skeletal muscle weakness in patients with heart failure","volume":"60","author":"Noda","year":"2023","journal-title":"Heart Lung"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1189884","DOI":"10.3389\/fcvm.2023.1189884","article-title":"Predictive value of blood urea nitrogen in heart failure: a systematic review and meta-analysis","volume":"10","author":"Duan","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0303870","DOI":"10.1371\/journal.pone.0303870","article-title":"Blood urea nitrogen\/creatinine ratio in heart failure: systematic review and meta-analysis","volume":"19","author":"Zhou","year":"2024","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1161\/ATVBAHA.123.320270","article-title":"Plasma proteomics identifies B2M as a regulator of pulmonary hypertension in heart failure with preserved ejection fraction","volume":"44","author":"Jheng","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"632318","DOI":"10.3389\/fcvm.2021.632318","article-title":"The prognostic significance of Anemia in patients with heart failure: a meta-analysis of studies from the last decade","volume":"8","author":"Xia","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e24228","DOI":"10.1002\/clc.24228","article-title":"Impact of anemia on clinical outcomes in patients with acute heart failure: a systematic review and meta-analysis","volume":"47","author":"Pan","year":"2024","journal-title":"Clin Cardiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/diagnostics14020209","article-title":"Anemia and iron deficiency predict all-cause mortality in patients with heart failure and preserved ejection fraction: 6-year follow-up study","volume":"14","author":"K\u00f6seo\u011flu","year":"2024","journal-title":"Diagnostics"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s10741-020-09927-x","article-title":"Diagnostic and prognostic value of serum C-reactive protein in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"26","author":"Lakhani","year":"2021","journal-title":"Heart Fail Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"131818","DOI":"10.1016\/j.ijcard.2024.131818","article-title":"High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: findings from TOPCAT","volume":"402","author":"Ferreira","year":"2024","journal-title":"Int J Cardiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11897-022-00584-9","article-title":"C-Reactive protein, interleukin-6, trimethylamine-N-oxide, syndecan-1, nitric oxide, and tumor necrosis factor receptor-1 in heart failure with preserved versus reduced ejection fraction: a meta-analysis","volume":"20","author":"Gui","year":"2023","journal-title":"Curr Heart Fail Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1253\/circrep.CR-25-0102","article-title":"Prognostic significance of peripheral monocyte counts in patients with chronic heart failure","volume":"7","author":"Nozuhara","year":"2025","journal-title":"Circ Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"110281","DOI":"10.1016\/j.isci.2024.110281","article-title":"Explainable machine learning for predicting 30-day readmission in acute heart failure patients","volume":"27","author":"Zhang","year":"2024","journal-title":"iScience"},{"key":"B31","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ehf2.15062","article-title":"Explainable machine learning and online calculators to predict heart failure mortality in intensive care units","volume":"12","author":"Chen","year":"2025","journal-title":"ESC Heart Fail"},{"key":"B32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/postmj\/qgae027","article-title":"Understanding decision curve analysis in clinical prediction model research","volume":"100","author":"Zhao","year":"2024","journal-title":"Postgrad Med J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1856570\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T06:18:22Z","timestamp":1786342702000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1856570\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":32,"alternative-id":["10.3389\/fcvm.2026.1856570"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1856570","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"1856570"}}